The German Supreme Court upholds law restrictive GM crop (AFP)

Berlin (AFP) – the German Supreme Court on Wednesday upheld two-year-old strong restrictions on the placing on the market in accordance with the law of the environment of genetically modified plants use, saying, it protected the public against the dangers of technology.

The Federal Constitutional Court, said the 2008 law require that the buffer zones between THE GM and non-hazardous plants was justified on the basis of the "contamination" and other plants, bulbs, roots and the open questions-of-the-art technology.

"Legislation branch carries out operations in accordance with the objectives and the legitimate public welfare should be given a generous space to take in order to realise these objectives, the regulation laying down certain technical measures for the status of the social and scientific discussion on a broad range of genetic engineering research of failure to use background," the Court said.

The law provides for the 150-m-very (490-feet-level) "protective area" genetically modified plants and standard cropland and organic crops, next to the 300 m wide gap.

GM fields must also be registered in such a way that all the co mingling the transaction to be traced back to the source and the corresponding obligation to refund imposes a contingent liability may be imposed on farmers.

The law had exported the product concerned to the European agricultural fund for rural development in the eastern part of Saxony-Anhalt State, even before it was passed in.

Environmental watchdog Greenpeace welcomes the decision by saying that "a risky technologies such as genetic engineering research of failure cannot be forced, by anyone".

"The Decision confirms that there are risks and risks associated with GM crops seeding," Stephanie Toewe group said in a statement.

The Secretary of the Ministry of agriculture, Robert Kloos, said, the Court of Justice "to protect the population and the environment and allows for the responsible use of GMOs," genetically modified organisms.

But the German Farmers ' Association said ihmisyksilöä co mingling presented "crops and uninsurable risks" in the field of application of the principle of responsibility and for this reason, we recommend that the planting of GM crops.

The European Union has tried to create a single line of GM, two plants currently authorised-maize position for use as animal feed--and whose paper potato with but another 15 decisions is deadlocked.

Countries and regions has subsequently prohibited cultivation unilaterally or expressed GM-free, that contains traces of blocked ports with the products.

The European Commission, the EU's executive arm, says the risk of breaching the guidelines on State aid for environmental protection policies in the world.


View the original article here

Comments

Post a Comment

Popular posts from this blog

Protein folding via charge zippers

Jan. 18, 2013 — Membrane proteins are the "molecular machines" in biological cell envelopes. They control diverse processes, such as the transport of molecules across the lipid membrane, signal transduction, and photosynthesis. Their shape, i.e. folding of the molecules, plays a decisive role in the formation of, e.g., pores in the cell membrane. In the journal Cell, researchers of Karlsruhe Institute of Technology and the University of Cagliari are now reporting a novel charge zipper principle used by proteins to form functional units. "It is fascinating to see the elegant basic principles that are used by nature to construct molecular assemblies," explains Anne Ulrich, Director of the KIT Institute for Biological Interfaces. "A charge zipper between the charged side chains is an entirely unexpected mechanism used by membrane proteins to neutralize their charges such that they can be immersed into hydrophobic cell membranes....
Read more

Lonza: CMC Product Manager

Due to the expansion of Lonza's Analytical Services department we are looking to recruit an Analytical Product Manager. Reporting to the Group Leader you will proactively coordinate internal and external client project activities (analytical CMC development of recombinant proteins) performed within Analytical Services and to provide scientific oversight of data generated for the projects. Responsibilities:      * Primary point of contact for all analytical activities relating to product development and management of analytical development programmes from early phase development through to license application.      * Primary interface to the Program Management Team, AS study directors and internal and external customers.      * Definition, presentation and representation of analytical CMC programmes to customers, potential new customers & external meetings, including oversight of large analytical portfolio projects.      * Design an...
Read more

GlaxoSmithKline (GSK): Esprit Physician Leadership Development Programme

Esprit Physician Leadership Development Programme Are you an MBBS or MD with experience gained in a pharmaceutical, biotech or academic environment eager to become an outstanding leader? An inquisitive mind who would thrive on a diverse, intellectually demanding global leadership programme? Do you want to translate your medical expertise into disease-beating medicines? And help people across the world to do more, feel better and live longer? We are a science-led, global healthcare company that puts patients first. Our business is focused on developing medicines that improve the quality of human life. To meet the future strategic challenges this entails, we need to fast-track the finest medical talent into senior leadership roles within our business. The Esprit Physician programme is an initial three-year, accelerated, multi-disciplinary and individually tailored programme. It is heavily backed by our senior management team, and it will give you incredible standing as a phys...
Read more